Search Results
Search for "Amikacin" returned 13 results
Showing 1-13 out of 13
| DrugBank ID | Name | Formula | Weight |
|---|---|---|---|
DB00479
|
Amikacin | C22H43N5O13 | 585.6025 |
| ... 0-11% 37768 9038 APRD00550 ANTIBIOTIC BB-K8 Amikacin Base Amikacin Dihydrate Amikacin Sulfate Amikacina [INN-Spanish] Amikacine [INN-French] Amikacinum [INN-Latin] BB-K8 amikacin 585.6025 585 ... | |||
| DB01330
|
Cefotetan | C17H17N7O8S4 | 575.6190 |
| ... The cephalosporin increases the anticoagulant effect Amikacin Increased risk of nephrotoxicity Anisindione The cephalosporin increases the anticoagulant effect Dicumarol The cephalosporin ... | |||
| DB01331
|
Cefoxitin | C16H17N3O7S2 | 427.4520 |
| ... The cephalosporin increases the anticoagulant effect Amikacin Increased risk of nephrotoxicity Anisindione The cephalosporin increases the anticoagulant effect Dicumarol The cephalosporin ... | |||
| DB01607
|
Ticarcillin | C15H16N2O6S2 | 384.4270 |
| Ticarcillin may inactivate Amikacin in vitro and the two agents should not be administered simultaneously through the same IV line. Demeclocycline Demeclocycline may reduce the effect of ... | |||
| DB00438
|
Ceftazidime | C22H22N6O7S2 | 546.5760 |
| Amikacin Increased risk of nephrotoxicity Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity Netilmicin Increased risk ... | |||
| DB00493
|
Cefotaxime | C16H17N5O7S2 | 455.4650 |
| Amikacin Increased risk of nephrotoxicity Gentamicin Increased risk of nephrotoxicity Kanamycin Increased risk of nephrotoxicity Neomycin Increased risk of nephrotoxicity Netilmicin Increased risk ... | |||
| DB00887
|
Bumetanide | C17H20N2O5S | 364.4160 |
| Amikacin Increased ototoxicity Cisplatin Increased ototoxicity Deslanoside Possible electrolyte variations and arrhythmias Digitoxin Possible electrolyte variations and arrhythmias Digoxin ... | |||
| DB01212
|
Ceftriaxone | C18H18N8O7S3 | 554.5800 |
| ... The cephalosporin increases the anticoagulant effect Amikacin Increased risk of nephrotoxicity Anisindione The cephalosporin increases the anticoagulant effect Dicumarol The cephalosporin ... | |||
| DB00695
|
Furosemide | C12H11ClN2O5S | 330.7440 |
| Amikacin Increased ototoxicity Cisplatin Increased ototoxicity Deslanoside Possible electrolyte variations and arrhythmias Digitoxin Possible electrolyte variations and arrhythmias Digoxin ... | |||
| DB00903
|
Ethacrynic acid | C13H12Cl2O4 | 303.1380 |
| ... Ethacrynic acid increases the anticoagulant effect Amikacin Increased ototoxicity Anisindione Ethacrynic acid increases the anticoagulant effect Cisplatin Increased ototoxicity Deslanoside ... | |||
| DB00955
|
Netilmicin | C21H41N5O7 | 475.5795 |
| ... strains have been identified which are resistant to amikacin but susceptible to netilmicin. The combination of netilmicin and penicillin G has a synergistic bactericidal effect against most ... | |||
| DB01041
|
Thalidomide | C13H10N2O4 | 258.2295 |
| Concomitant therapy should be avoided. Amikacin Thalidomide increases the renal toxicity of the aminoglycoside Anakinra Thalidomide may increase the adverse effects of Anakinra. Increased risk of ... | |||
| DB00864
|
Tacrolimus | C44H69NO12 | 804.0182 |
| Concomitant therapy should be used with caution. Amikacin Additive renal impairment may occur during concomitant therapy with aminoglycosides such as Amikacin. Use caution during concomitant therapy. | |||
Showing 1-13 out of 13